Sector ratings Merck KGaA

Stocks

Real-time Estimate Tradegate Other stock markets 14:59:41 21/07/2026 +04			5-day change	1st Jan Change
131.60 ^EUR	-2.48%		-4.95%	+8.16%

07-20	MERCK KGAA : UBS remains its Buy rating	ZD
07-16	Merck Opens BioReliance Testing Facility in Darmstadt Germany	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
MERCK KGAA	66.94B		AAA
MERCK & CO., INC.	307B		A
HALOZYME THERAPEUTICS, INC.	9.14B		BBB
KYOWA KIRIN CO., LTD.	8.55B		AA
SK BIOPHARMACEUTICALS CO., LTD.	4.07B		AAA
BETTA PHARMACEUTICALS CO., LTD.	3.6B		-			-	-
YUHAN CORPORATION	3.49B		AA
SUPERNUS PHARMACEUTICALS, INC.	2.75B	-	BB	-		-
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	2.17B	-	-	-	-	-	-	-
SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.	1.88B	-	-	-		-	-
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	1.76B	-	-	-		-	-	-
VELOXIS PHARMACEUTICALS A/S	1.64B	-	-	-	-	-	-	-
SHANGHAI YIZHONG PHARMACEUTICAL CO., LTD.	1.23B	-	-	-	-	-	-	-
ETON PHARMACEUTICALS, INC.	1.13B	-	-	-		-
FRONTIER BIOTECHNOLOGIES INC.	1.15B	-	-	-	-	-	-	-
MEZZION PHARMA CO.,LTD.	1.07B	-	BBB	-	-	-	-	-
KISSEI PHARMACEUTICAL CO., LTD.	1.06B		BBB
CHANGCHUN BCHT BIOTECHNOLOGY CO.	900M		-			-	-
SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.,LTD.	896M	-	-	-	-	-	-	-
DBV TECHNOLOGIES	839M	-	-	-		-
Average	21.08B		AA
Weighted average by Cap.			AA